Selective treatments for chronic rhinosinusitis
View Patent ↗Method for treating chronic rhinosinusitis in a human patient. In the method a photosensitizing agent such as indocyanine green can be applied to color a nasal or sinal treatment site harboring infectious microorganisms. The photosensitizing agent can have an energy absorption peak in a near infrared wavelength region of the electromagnetic spectrum. The method can also include applying light energy from a laser source at a near infrared wavelength or wavelengths to the colored treatment site, for a duration sufficient to control the microorganisms. Apparatus for performing the method is also disclosed.
1. A method of treating chronic rhinosinusitis in a human patient, the method comprising:
applying a photosensitizing agent comprising indocyanine green to color a nasal or sinal treatment site harboring infectious microorganisms, the photosensitizing agent having an energy absorption peak in a near infrared wavelength region of the electromagnetic spectrum; and
applying light energy having an energy density from about 50 J/cm 2 to about 500 J/cm 2 from a laser source at a near infrared wavelength or wavelengths to the colored treatment site, for a duration sufficient to control the microorganisms.
2. A method according to claim 1 comprising employing one or more or all of the following conditions:
a dosage of indocyanine green sufficient to color tissue at the treatment site to be visibly green when viewed endoscopically;
light energy in a near infrared wavelength region of from about 780 nm to about 850 nm;
light energy applied from a source outputting at a power of from about 2 W to about 15 W;
light energy applied for a duration of from about 30 seconds to about 480 seconds;
a light energy dosage applied for a duration of from about 30 seconds to about 480 seconds; and
repeating the application of photosensitizing agent and of the light energy from one to five additional times.
3. A method according to claim 1 comprising diffusing the applied light from a source extending into the nasal cavity.
4. A method according to claim 1 comprising taking a diagnostic tissue culture from the treatment site prior to application of a photosensitizing agent to determine the presence of one or more infectious microorganisms at the treatment site.
5. A method according to claim 4 comprising selecting a patient for treatment according to the infectious microorganisms identified in the culture.
6. A method according to claim 1 comprising collecting a tissue culture from the treatment site after the treatment and evaluating the efficacy of the treatment from the collected tissue culture.
7. A method of treating chronic rhinosinusitis in a human patient, the method comprising:
applying a photosensitizing agent having a peak absorbency in the near infrared region to color a nasal or sinal treatment site harboring infectious microorganisms, the photosensitizing agent optionally appearing visibly green when coated on a white substrate and having an energy absorption peak in a near infrared wavelength region of the electromagnetic spectrum; and
applying light energy having an energy density from about 50 J/cm 2 to about 500 J/cm 2 from a laser source at a near infrared wavelength or wavelengths to the colored treatment site, for a duration sufficient to control the microorganisms.
8. A method according to claim 1 wherein a laser diode or a light-emitting diode provides the light energy and a light applicator transmits the light energy to the treatment site.
9. A method according to claim 1 wherein the applied indocyanine green is in the range of from about 10 μg to about 500 μg.
10. A method according to claim 1 wherein the light energy is applied from a source outputting at a power of from about 2 W to about 15 W.
11. A method according to claim 1 wherein an energy density at the treatment site is from about 100 J/cm 2 to about 300 J/cm 2 .
12. A method according to claim 2 wherein the dosage of indocyanine green is in the range of from about 10 μg to about 500 μg.
13. A method according to claim 2 wherein the light energy is in a near infrared wavelength region of from about 800 nm to about 820 nm.
14. A method according to claim 2 wherein the light energy is applied from a source outputting at a power of from about 4 W to about 8 W.
15. A method according to claim 2 wherein the light energy is applied for a duration of from about 120 seconds to about 300 seconds.
16. A method according to claim 2 including a time interval between repeated photosensitizing agent and light energy applications of from about 3 days to about 14 days.
17. A method according to claim 3 comprising diffusing the light laterally in all or most radial directions from a source having an approximately cylindrical, conical, spherical, part-spherical or other suitable configuration.